Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tezosentan in Acute Heart Failure (VERITAS 2)
NCT00524433Phase 3Completed
- Sponsor
- Idorsia
- Start
- Apr 2003
- Primary completion
- Jan 2005
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of tezosentan in Acute Heart Failure (AHF), sponsored by Idorsia. Started Apr 2003; status: completed.
02
Drugs
tezosentan
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on NCT00524433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00524433.